In eye diseases like DR, high blood glucose and oxidative stress activate the Notch1-Hes signaling pathway, leading to ECM imbalance and promoting vascular dysfunction, inflammation, and retinal damage (Fan et al., 2020)
Truly one of the best healthcare experiences Ive had
Early research findings indicate that BPC-157 activates the FAKpaxillin pathway in cells, promoting cell migration and survival at injury sites
So patients who advance too quickly to a higher dose typically have more severe side effects and may not be able to tolerate the medication. There is no secret extra dose The idea of a golden dose may be tempting for patients, but safety must come first
10.1007/s11104-005-3900-1 143 RichauK
10.1677/joe.0.1580121 340